Histology-Independent Study of Palbociclib in Patients With Advanced Cancer
NCT03123744
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No study funding available.
Conditions
Cancer, Advanced
Interventions
DRUG:
Palbociclib 125mg
Sponsor
Razelle Kurzrock, MD